This work represents the first demonstration of integrated flexible electronics for chronic, multi-site electrophysiological monitoring throughout 3D neural tissue constructs. The platform's compatibility with standard laboratory culture consumables positions it as a potentially scalable tool for neuroscience research and pharmaceutical applications. By enabling routine functional assessment of organoid models, this technology contributes to European strategic objectives including development of human-relevant alternatives to animal experimentation (3Rs principles) and acceleration of drug discovery for neurological disorders affecting millions of Europeans. Primary end-users include academic laboratories studying brain development and disease, pharmaceutical companies conducting screening assays, and emerging personalized medicine applications. While current technology readiness remains at proof-of-concept stage, the successful demonstration of key functionalities establishes a foundation for future commercial development in the rapidly growing organoid electrophysiology market.